Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: In situaromatase expression in primary tumor is associated with estrogen receptor expression but is not predictive of response to endocrine therapy in advanced breast cancer

Figure 3

Time to progression (TTP) according to high, low and negative PR expression in aromatase positive primary tumours from patients treated with letrozole or tamoxifen. (A) Letrozole treatment, Aromatase positive, PR high, n = 16; Aromatase positive, PR low, n = 8; Aromatase positive, PR neg., n = 5. (B) Tamoxifen treatment, Aromatase positive, PR high, n = 9; Aromatase positive, PR low, n = 11; Aromatase positive, PR neg., n = 9.

Back to article page